The Niche, Knoepfler lab stem cell blog. June 1, 2016.
The REGROW Act would drastically weaken FDA regulation of experimental stem cell therapies.
Patient Groups Opposing REGROW
Cystic Fibrosis Foundation
Friedreich’s Ataxia Research Alliance
Friends of Cancer Research
Global Genes
Michael J. Fox Foundation for Parkinson’s Research
Myotonic Dystrophy Foundation
National MS Society
National Organization for Rare Disorders
National Patient Advocate Foundation
Prevent Cancer Foundation
Friday, June 3, 2016
Subscribe to:
Posts (Atom)
